Clinical Trial Update: Prognostic Value of SPECT-CT Quantitative Indices for the Response Assessment of Bone Metastatic Prostate Carcinoma

View source ↗

Summary

This clinical trial update investigates whether SPECT-CT quantitative indices can prognostically predict response in bone-metastatic prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University Hospital, Brest | Conditions: Prostate Cancer | Status: COMPLETED